What are the diagnostic criteria for fibrous dysplasia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Fibrous Dysplasia

Fibrous dysplasia is diagnosed through the integration of clinical presentation (painless bone swelling, deformity, or incidental finding), characteristic radiographic features (ground-glass appearance on imaging), and histopathological confirmation showing replacement of normal bone and marrow by fibrous tissue. 1, 2

Clinical Presentation

The clinical diagnosis begins with recognizing the pattern of bone involvement:

  • Monostotic form (single bone involvement) is most common, occurring in approximately 70-80% of cases and frequently identified incidentally as asymptomatic lesions 1, 2
  • Polyostotic form (multiple bone involvement) affects multiple skeletal sites and may be associated with endocrine dysfunction and café-au-lait spots (McCune-Albright syndrome) 3
  • Craniofacial fibrous dysplasia involves the skull base and facial bones, with long bones, ribs, and craniofacial bones being the most commonly affected sites 2, 4

Key clinical features include bone pain, bone deformities, pathologic fractures, and painless swelling that develops gradually over months to years 1, 3, 4

Radiographic Criteria

Imaging is essential for diagnosis and should include:

  • CT scanning is the primary imaging modality, revealing the characteristic "ground-glass" appearance of lesions with ill-defined borders 4, 5
  • MRI with gadolinium enhancement is useful for differentiating fibrous dysplasia from other fibro-osseous lesions, identifying neoplastic foci within dysplastic tissue, and distinguishing benign from malignant bone lesions 5
  • Radiographic findings show expansion of affected bone with a ground-glass or hazy appearance on plain films and CT 2, 4

A critical caveat: MRI enhancement patterns must be carefully interpreted, as irregular or intense enhancement may indicate malignant transformation (fibrosarcoma) or alternative diagnoses such as multiple myeloma or ossifying fibroma 5

Histopathological Confirmation

Definitive diagnosis requires biopsy showing:

  • Replacement of normal bone and marrow by fibrous tissue 1
  • Characteristic histological pattern of fibro-osseous tissue 2, 3
  • Biopsy is indicated for confirmatory diagnosis, especially when radiographic findings are atypical or when malignant transformation is suspected 2, 5

Genetic Basis

The underlying etiology involves:

  • Activating mutation in the GNAS gene (encoding the alpha subunit of stimulatory G protein) located at chromosome 20q13.2-13.3 2, 3
  • This is a post-zygotic, non-inheritable mutation resulting in osteoblastic differentiation defects 3

Differential Diagnosis Considerations

When evaluating suspected fibrous dysplasia, exclude:

  • Ossifying fibroma 5
  • Multiple myeloma (particularly if irregular MRI enhancement is present) 5
  • Low-grade fibrosarcoma (malignant transformation, identified by intense enhancement on MRI) 5
  • Myeloproliferative disease 5

The combination of CT and contrast-enhanced MRI is recommended for comprehensive evaluation, as MRI proves particularly useful in defining clinical behavior and identifying potential malignant foci within dysplastic tissue 5

References

Research

Fibrous dysplasia-recent concepts.

Journal of pharmacy & bioallied sciences, 2015

Research

Fibrous dysplasia. Pathophysiology, evaluation, and treatment.

The Journal of bone and joint surgery. American volume, 2005

Research

Fibrous dysplasia of bone and McCune-Albright syndrome.

Best practice & research. Clinical rheumatology, 2008

Research

CT Imaging of Craniofacial Fibrous Dysplasia.

Case reports in dentistry, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.